Prestige Consumer Healthcare (PBH) reported $296.52 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 7.1%. EPS of $1.32 for the same period compares to $1.02 a year ago.
The reported revenue represents a surprise of +2.62% over the Zacks Consensus Estimate of $288.95 million. With the consensus EPS estimate being $1.30, the EPS surprise was +1.54%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Prestige Consumer Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- OTC Healthcare- International: $47.57 million compared to the $47.57 million average estimate based on three analysts. The reported number represents a change of +3.7% year over year.
- Revenues- OTC Healthcare- North American: $248.95 million versus $241.66 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +7.7% change.
- Gross profit- OTC Healthcare- North American: $141.49 million compared to the $136.93 million average estimate based on two analysts.
- Gross profit- OTC Healthcare- International: $28.52 million versus the two-analyst average estimate of $28.03 million.
View all Key Company Metrics for Prestige Consumer Healthcare here>>>
Shares of Prestige Consumer Healthcare have returned -2.1% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Prestige Consumer Healthcare Inc. (PBH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
